期刊文献+

脂联素与维吾尔族非酒精性脂肪肝病的关系 被引量:3

Relationship between adiponectin and non-alcoholic fatty liver disease in Uygur national minority
下载PDF
导出
摘要 目的:探讨脂联素与维吾尔族非酒精性脂肪肝病(non-alcoholic fatty liver disease,NAFLD)的关系.方法:选择非酒精性脂肪肝患者260人(脂肪肝组)和健康对照129人(正常对照组),均为维吾尔族,检测血压、身高、体质量,抽取空腹及OGTT的2h静脉血,检测血脂、胰岛素、血糖及脂联素水平,计算BMI、HOMA-IR,分析脂联素与NAFLD及上述指标的关系.结果:在校正性别、年龄、BMI、SBP、DBP、TC、HDL、LDL、TG、FBG、PBG、FINS、PINS的影响因素后,与正常组相比,脂肪肝组血清脂联素水平降低,差异具有统计学意义;而脂肪肝组患病率、BMI、SBP、DBP、TC、HDL、LDL、TG、FBG、PBG、FINS、HOMA-IR水平随着血清脂联素的增高呈现下降趋势(P<0.05);Logistic回归分析结果提示在校正了性别、年龄、BMI、SBP、DBP、HOMA-IR、TC、HDL、LDL、TG、FBG、PBG、FINS、PINS的影响的情况下,以血清脂联素四分位最低层为对照,第二、三、四分位层时患脂肪肝的OR值分别为0.460(P=0.031)、0.449(P=0.022)、0.099(P=0.000).结论:维吾尔族NAFLD脂联素水平降低,亦是其独立危险因素. AIM: To investigate the relation of adiponectin with non-alcoholic fatty liver disease (NAFLD) in Uygur national minority.METHODS: Two hundred and sixty patients with non-alcoholic fatty liver disease (NAFLD) served as fatty liver disease group, while 129 healthy people served as normal control group who were all Uygur nationality. Blood pressure, height, physique were measured and 2-hour intravenous blood of empty stomach and OGTT were collected to measure blood fat, insulin, blood glucose and adiponectin level. BMI and HOMA-IR were assessed. Relationship of lipoprotein with NAFLD and with index described above were analyzed and investigated.RESULTS: After correcting such confounding factors as sex, age, BMI, SBP, DBP, TC, HDL, LDL, TG, FBG, PBG, FINS, PINS, serum adiponectin level was significantly reduced in fatty liver group compared with normal group. And the incidence rate, BMI, SBP, DBP, TC, HDL, LDL, TG, FBG, PBG, FINS, HOMA-IR level decreased as serum lipoprotein increased (P 〈 0.05). Logistic return analysis showed that after consideration of confounding factors such as sex, age, BMI, SBP, DBP, HOMA-IR, TC, HDL, LDL, TG, FBG, PBG, FINS, PINS, the OR values for second, third and four layer were 0.460 (P = 0.031), 0.449 (P = 0.022), 0.099 (P = 0.000) respectively compared with the first layer CONCLUSION: NAFLD adiponectin level is lower in Uygur nationality, and is also an inde- pendent risk factor.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第7期672-676,共5页 World Chinese Journal of Digestology
关键词 维吾尔族 非酒精性脂肪肝 脂联素 Uygur Non-alcoholic fatty liver disease Adiponectin
  • 相关文献

参考文献12

  • 1Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis 2004; 8: 575-594, ix
  • 2Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87: 2764-2769
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 4Lopez-Bermejo A, Botas P, Funahashi T, Delgado E, Kihara S, Ricart W, Fernandez-Real JM. Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin Endocrinol (Oxf) 2004; 60:256-263
  • 5Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D,Erickson MR, Yen FT, Bihain BE, Lodish HF. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 2001; 98:2005-2010
  • 6Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769
  • 7Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002; 35:746-752
  • 8Diez JJ, Iglesias P. The role of the novel adipocytederived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148:293-300
  • 9Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D, Hammond CD, Rafaeloff-Phail R, Seng T, Suter TM, Sluka JP, Ravussin E, Gadski RA, Caro JF. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 2000; 1:81-88
  • 10Halse R, Pearson SL, McCormack JG, Yeaman SJ, Taylor R. Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. Diabetes 2001; 50:1102-1109

二级参考文献31

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Sorrentino P, Tarantino G, Conca P, et al. Silent non-alcoholic fatty liver disease: a clinical histological study. J Hepatol, 2004,41:751-757.
  • 3Seidell JC. Obesity, insulin resistance and diabetes-a world wide epidemic. Br J Nutr, 2000, 83(Suppl 1): S5-8.
  • 4Jansen PL. Non-alcoholic steatohepatitis. Eur J Gastroenterol Hepatol, 2004, 16: 1079-1085.
  • 5Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. Gastroenterol Hepatol, 2002, 17: 1098-1105.
  • 6Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin liver Dis, 2004, 8: 575-594.
  • 7Day CP. The potential role of gene in nonalcoholic fatty liver disease. Clin liver Dis, 2004, 8: 673-691.
  • 8Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin liver Dis, 2004, 8: 639-671.
  • 9Feldstein A, Gores GJ. Steatohepatitis and apoptosis: therapeutic implications. Am J Gastroenterol, 2004, 99: 1718-1719.
  • 10Pessayre D, Fromenty B, Mansouri A. Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol, 2004, 16: 1095-1105.

共引文献1558

同被引文献49

  • 1Yu-Tao Zhan,Wei An.Roles of liver innate immune cells in nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2010,16(37):4652-4660. 被引量:35
  • 2中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):43-48. 被引量:470
  • 3丁效蕙,赵景民.非酒精性脂肪性肝炎的发病机制及治疗的研究进展[J].世界华人消化杂志,2005,13(3):371-375. 被引量:27
  • 4中华医学会肝病学分会脂肪肝和酒精性肝病学组非酒精性脂肪性肝病诊疗指南.中华肝脏病杂志2006;14:161-163.
  • 5Musso G, Gambino R, De Michieli F, Durazzo M, Pagano G, Cassader M. Adiponectin gene poly- morphisms modulate acute adiponectin responseto dietary fat: Possible pathogenetic role in NASH. Hepatology 2008; 47:1167-1177.
  • 6Chitturi S, Abeygunasekera S, Farrell GC, Holmes- Walker J, Hui JM, Fung C, Karim R, Lin R, Samar- asinghe D, Liddle C, Weltman M, George J. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syn- drome. Hepatology 2002; 35:373-379.
  • 7Seppali-Lindroos A, Vehkavaara S, Hikkinen AM, Goto T, Westerbacka J, Sovijirvi A, Halavaara J, Yki-Jirvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids inde- pendent of obesity in normal men. J Clin Endocrinol Metab 2002; 87:3023-3028.
  • 8Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N. Is adiponectin involved in the patho- genesis of nonalcoholic steatohepatitis? A preliminary human study. J Clin Gastroentero12005; 39:237-242.
  • 9Pagano C, Soardo G, Esposito W, Fallo F, Basan L, Donnini D, Federspil G, Sechi LA, Vettor R. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol 2005; 152:113-118.
  • 10Targher G, Bertolini L, Rodella S, Zoppini G, Scala L, Zenari L, Falezza G. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 2006; 64:679-683.

引证文献3

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部